| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/30/2023 | 23.04% | Raymond James | $36 → $33 | Maintains | Outperform |
| 07/27/2023 | 34.23% | Raymond James | $38 → $36 | Maintains | Outperform |
| 07/26/2023 | 26.77% | Stephens & Co. | → $34 | Reiterates | Overweight → Overweight |
| 04/26/2023 | 41.69% | Raymond James | $43 → $38 | Maintains | Outperform |
| 04/06/2023 | 60.33% | Raymond James | $50 → $43 | Maintains | Outperform |
| 02/21/2023 | 86.43% | Raymond James | → $50 | Downgrades | Strong Buy → Outperform |
| 01/30/2023 | 86.43% | Raymond James | $52 → $50 | Maintains | Strong Buy |
| 10/26/2022 | 93.89% | Raymond James | $48 → $52 | Maintains | Strong Buy |
| 07/07/2022 | 78.97% | Raymond James | → $48 | Upgrades | Outperform → Strong Buy |
| 07/29/2021 | 78.97% | Janney Montgomery Scott | → $48 | Upgrades | Neutral → Buy |
| 07/28/2021 | 75.24% | Raymond James | $55 → $47 | Maintains | Outperform |
| 04/27/2021 | 105.07% | Raymond James | $46 → $55 | Maintains | Outperform |
| 02/01/2021 | 71.51% | Raymond James | → $46 | Upgrades | Market Perform → Outperform |
| 11/12/2020 | — | Stephens & Co. | Upgrades | Equal-Weight → Overweight | |
| 10/29/2020 | 4.4% | Piper Sandler | $27 → $28 | Maintains | Overweight |
| 09/29/2020 | 0.67% | Piper Sandler | $30 → $27 | Maintains | Overweight |
| 04/27/2020 | 8.13% | Raymond James | $28 → $29 | Reiterates | → Outperform |
| 04/24/2020 | 11.86% | Piper Sandler | $32 → $30 | Maintains | Overweight |
| 04/09/2020 | — | Stephens & Co. | Downgrades | Overweight → Equal-Weight | |
| 02/03/2020 | 64.06% | Raymond James | $43 → $44 | Maintains | Outperform |
| 10/25/2019 | 60.33% | Raymond James | $39 → $43 | Maintains | Outperform |
| 07/09/2019 | 64.06% | Stephens & Co. | → $44 | Upgrades | Equal-Weight → Overweight |
| 04/09/2019 | 56.6% | Raymond James | → $42 | Initiates Coverage On | → Outperform |
| 11/19/2018 | 75.24% | Piper Sandler | → $47 | Upgrades | Hold → Buy |
What is the target price for First Merchants (FRME)?
The latest price target for First Merchants (NASDAQ: FRME) was reported by Raymond James on October 30, 2023. The analyst firm set a price target for $33.00 expecting FRME to rise to within 12 months (a possible 23.04% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for First Merchants (FRME)?
The latest analyst rating for First Merchants (NASDAQ: FRME) was provided by Raymond James, and First Merchants maintained their outperform rating.
When is the next analyst rating going to be posted or updated for First Merchants (FRME)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of First Merchants, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for First Merchants was filed on October 30, 2023 so you should expect the next rating to be made available sometime around October 30, 2024.
Is the Analyst Rating First Merchants (FRME) correct?
While ratings are subjective and will change, the latest First Merchants (FRME) rating was a maintained with a price target of $36.00 to $33.00. The current price First Merchants (FRME) is trading at is $26.82, which is out of the analyst's predicted range.